CV6 Therapeutics (NI) Ltd

Curve Therapeutics

This biotechnology company develops small molecule and cyclic peptide drugs for pharmaceutical partners and patients to treat cancer, immunology and inflammatory diseases.

CV Therapeutics

This biopharmaceutical company develops and commercialises small molecule drugs for patients with cardiovascular diseases, including chronic angina and myocardial perfusion imaging needs.

HDAX Therapeutics

This biotechnology company develops small molecule inhibitors targeting the HDAC6 protein to treat patients with neuropathies, heart failure and various cancer conditions.

SFA Theraputics

This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.

Tipping Point Biosciences

This biotechnology company develops a drug discovery platform and small molecule therapies targeting dysfunctional DNA packaging for patients with cancer and neurodegenerative diseases.

Ribon Therapeutics

This biotechnology company develops small molecule inhibitors targeting stress support pathways for patients with cancer and inflammatory diseases.

BlossomHill Therapeutics

This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.